Amplifon S.p.A.
Amplifon S.p.A. (AMFPF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
amfpf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Amplifon S.p.A. (AMFPF) measures how much investors pay for each dollar of the company's trailing earnings. AMFPF's current PE ratio of 34.01x is calculated by dividing its stock price of $12.01 by its TTM earnings per share of $0.31. −16.9% discount vs 5Y avg 40.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 14 fiscal years · Front-end computedMinQ1 · 25%33.3x
MedianQ3 · 75%70.3x
Max
At 34.01x, AMFPF's current P/E is within its average historical range over the past 14 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Amplifon S.p.A.You AMFPF | $2.6B | 34.01x | +40.3% | $0.31 |
 Ambu A/S AMBBY | $2.6B | 43.18x | +78.2% | $2.15 |
 Bumrungrad Hospital Public Company Limited BUGDF | $3.8B | 18.03x | -25.6% | $9.44 |
 Bumrungrad Hospital Public Company Limited BUHPF | $4.3B | 18.86x | -22.2% | $9.44 |
 Carl Zeiss Meditec AG CZMWF | $2.7B | 26.20x | +8.1% | $1.61 |
 Carl Zeiss Meditec AG CZMWY | $2.6B | 26.34x | +8.7% | $1.61 |
 MediPal Holdings Corporation MAHLY | $3.9B | 12.80x | -47.2% | $219.14 |
Industry Average 6 peers with valid PE | — | 24.24x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 32.84x | $0.40 | -15.8% | |
2024-12-31 FY2024 | 39.00x | $0.64 | +6.3% | |
2023-12-31 FY2023 | 36.68x | $0.69 | +25.0% | |
2022-12-31 FY2022 | 29.34x | $0.80 | -56.1% | |
2021-12-31 FY2021 | 66.82x | $0.70 | -5.0% | |
2020-12-31 FY2020 | 70.34x | $0.45 | +53.0% | |
2019-12-31 FY2019 | 45.97x | $0.49 | +57.3% | |
2018-12-31 FY2018 | 29.22x | $0.51 | +83.5% | |
2017-12-31 FY2017 | 15.92x | $0.54 | -51.4% | |
2016-12-31 FY2016 | 32.79x | $0.30 | -3.2% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Amplifon S.p.A. (AMFPF) measures how much investors pay for each dollar of the company's trailing earnings. AMFPF's current PE ratio of 34.01x is calculated by dividing its stock price of $12.01 by its TTM earnings per share of $0.31.
Frequently asked questions
AMFPF pe ratio · 6 questionsAMFPF's current PE ratio is 34.01x as of 2026-06-09, based on a stock price of $12.01 and TTM EPS of $0.31. Data sourced from Financial Modeling Prep via AMFPF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Amplifon S.p.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09